Thamolwan Surakiatchanukul, MD
Ophthalmology · Lebanon, NHNPI 1902398415
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (48.5%), food and beverage and grants — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 41.7% of the total. Reporting peaked in 2023 at $4,708 and has fallen 99.2% since, to $39 in 2025.
Across 56 payments — averaging $124.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$3K
- Regeneron$1K
- Alcon$1K
- Apellis Pharmaceuticals, Inc.$307
- Glaukos Corporation$146
- Regeneron Healthcare Solutions, Inc.$125
- plus $601 from 8 others
What the payments were for
- Grants$70010%
- Travel & lodging$3,38548%
- Food & beverage$2,79540%
- Education$1001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 28 | $2,907 |
| Regeneron | 10 | $1,462 |
| Alcon | 4 | $1,431 |
| Apellis Pharmaceuticals, Inc. | 3 | $307 |
| Glaukos Corporation | 1 | $146 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Eyepoint US, Inc. | 1 | $122 |
| Oyster Point Pharma, Inc. | 1 | $106 |
| AbbVie | 1 | $100 |
| Amgen | 2 | $91 |
| Astellas Pharma US Inc | 1 | $86 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $55 |
| Aerie Pharmaceuticals, Inc. | 1 | $23 |
| AstraZeneca | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELLARIS ELITE$1,040
- STELLARIS$993
- OPHTHALMIC INSTRUMENTS$993
- EYLEA$399
- EYLEA HD$275
- iStent Trabecular Micro-Bypass System Model iS3$146
- EYP-1901$122
- Syfovre$122
- TYRVAYA$106
How this compares
$6,980 in reported general payments places this provider in the 85th percentile of 80 ophthalmology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 15 | $499 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Lebanon
- Andrew CatomerisLebanon$56K
- Suzanne MichalakLebanon$4K
- Sabrina KhalilLebanon$2K
- Donald MillerLebanon$638
- Laura GadzalaLebanon$519
- Anthony CastelbuonoLebanon$448
- William GensheimerLebanon$434
- Eric SteffenLebanon$215
- Dane SlentzDerry$127K
- Jason SzelogPortsmouth$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.